Results 161 to 170 of about 32,727 (216)

Nitration in cancer signaling. [PDF]

Redox Biol
Claassen I, Adrita N, Chandler KB, Black SM, Roberts BR, Estevez AG, Beckman JS, Franco MC.   +7 more
europepmc   +1 more source

Redox regulation meets metabolism: targeting PRDX2 to prevent hepatocellular carcinoma. [PDF]

Mol Oncol
Goikoetxea-Usandizaga N, Martinez-Chantar ML, Conter C.   +2 more
europepmc   +1 more source

Targeting CTC Heterogeneity: Aptamer-Based Liquid Biopsy Predicts Outcome in Lung Cancer. [PDF]

Cancers (Basel)
Krat AV, Zamay GS, Veprintsev DV, Kirichenko DA, Kolovskaya OS, Zamay TN, Glazyrin YE, Minic Z, Sidorov SA, Komissarova VA, Zukov RA, Berezovski MV, Kichkailo AS.   +12 more
europepmc   +1 more source

Mechanism-based peroxiredoxin 3 inhibitors exploit a covalent warhead for cancer therapy. [PDF]

Sci Adv
Nelson KJ, Smalley TL, Messier T, Gumpena R, Gandhi U, Milczarek S, Habibovic A, Hoffman H, Gibson V, Hondal RJ, Lowther WT, Cunniff B.   +11 more
europepmc   +1 more source

Low expression of SOD and PRX4 as indicators of poor prognosis and systemic inflammation in colorectal cancer. [PDF]

Front Oncol
An S, Kwon HY, Kim K, Kim SK, Kim CS, Kim B, Do H, Kim Y.   +7 more
europepmc   +1 more source

Aging, oxidative stress, and cataracts: Therapeutic prospects and translational insights into peroxiredoxin 6. [PDF]

Prog Retin Eye Res
Kubo E, Chhunchha B, Singh DP.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Peroxiredoxins

Biological Chemistry, 2002
Present knowledge on peroxiredoxins is reviewed with special emphasis on catalytic principles, specificities and biological function. Peroxiredoxins are low efficiency peroxidases using thiols as reductants. They appear to be fairly promiscuous with respect to the hydroperoxide substrate; the specificities for the donor substrate vary considerably ...
Birgit, Hofmann, Hans-Jürgen, Hecht, Leopold, Flohé   +2 more
openaire   +2 more sources